510(k) Report

510(k) · Cleared

Cleared

Hemochron Model 8000/Factor VI Premier Coagulation

K930068510(k) TraditionalCleared Sep 2, 1993239-day reviewClass II21 CFR 864.5425

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Technidyne Corp. · JPA System, Multipurpose For In Vitro Coagulation Studies

Cleared on Sep 2, 1993 after a 239-day review. FDA lists a 510(k) statement for it but has not posted the file, so its predicates are not known. 2 later devices descend from it.

Decided
Sep 2, 1993
Review
239 days
Class
Class II
Product code
JPA
Recalls
None
Predicates
0

2 later devices descend from it, 1 citing it directly.

Descendants, by year cleared 1999: 1 descendant cleared2003: 1 descendant cleared1990200020102020
  1. This deviceK930068 Hemochron Model 8000/Factor VI Premier CoagulationTechnidyne Corp. · 1993
  2. Descendant · cites it directly · 1 of its ownK983475 Hemochron ResponseInternational Technidyne Corp. · 1999 · Recalled
  3. Descendant · 2 generations on · 0 of its ownK030818 Hemochron Response/SystemInternational Technidyne Corp. · 2003

Most influential descendants

Showing 2 of 2 · See all
  • K983475Hemochron ResponseInternational Technidyne Corp. · 1999 · cites it directly1descendant
  • K030818Hemochron Response/SystemInternational Technidyne Corp. · 2003 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K930068Hemochron Model 8000/Factor VI Premier CoagulationTechnidyne Corp.1993—
+1K983475Hemochron ResponseInternational Technidyne Corp.19991
+2K030818Hemochron Response/SystemInternational Technidyne Corp.2003—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
199910
200310
FIG. 1 — Lineage of K930068, 1993–2003Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in JPA? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new JPA device

  1. #1 K243858 TEG 6s Hemostasis System Citrated: K, KH, RT…score 12.0 · 2 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against?

FDA lists a 510(k) statement for it but has not posted the file, so its predicates are not known.

What descends from it? (2)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K983475Hemochron ResponseInternational Technidyne Corp.19991

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K983475 (International Technidyne Corp., 1999) has gone furthest, with 1 descendant of its own.

How does its category compare?

All JPA devices

JPA System, Multipurpose For In Vitro Coagulation Studies: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · JPA

3in 2025

2007: 12008: 22009: 62010: 12011: 12013: 12015: 22016: 62017: 42018: 12019: 32021: 12022: 12023: 32024: 12025: 32026 (partial year): 1
2007high 6 (2009) · low 0 (2012)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · JPA

30in 2025

2009: 91 days median2016: 114 days median2017: 117 days median2019: 175 days median2023: 506 days median2025: 30 days median
2007high 506 (2023) · low 30 (2025)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · JPA

1in 2020

2007: 12010: 62011: 42012: 12016: 32020: 12026 (partial year): 1
2007high 6 (2010) · low 0 (2008)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · JPA

11in 2025

2007: 1,7442008: 9182009: 1,3632010: 7272011: 1612012: 522013: 432014: 482015: 452016: 62017: 152018: 392019: 272020: 182021: 72022: 92023: 112024: 82025: 11
2007high 1,744 (2007) · low 6 (2016)2025

MAUDE reports naming product code JPA, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—11,744
20082—0918
200969101,363
20101—6727
20111—4161
20120—152
20131—043
20140—048
20152—045
2016611436
20174117015
20181—039
20193175027
20200—118
20211—07
20221—09
20233506011
20241—08
2025330011
20261—1—
Cite this page

510(k) Report. “K930068: Hemochron Model 8000/Factor VI Premier Coagulation.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K930068

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026